LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)	B-cell neoplasm, Central Nervous System Neoplasms, Primary, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, central nervous system cancer, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, nervous system disorder	Active, not recruiting	Phase 1 / Phase 2	2025-09-25		NCT04446962

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Institut Curie	48
National Cancer Institute, France	61

28 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centre Henri Becquerel	Rouen	France	10
Centre Lacassagne	Nice	France	2
CH Colmar	Colmar	France	2
CH côte Basque	Bayonne	France	1
CHRU Lille	Lille	France	1
CHU Amiens	Amiens	France	49
CHU Angers	Angers	France	87
CHU Besançon	Besançon	France	32
CHU Caen	Caen	France	48
CHU Clermont-Ferrand	Clermont-Ferrand	France	62
CHU Créteil	Créteil	France	2
CHU Dijon	Dijon	France	37
CHU Grenoble	Grenoble	France	48
CHU La Timone Marseille	Marseille	France	2
CHU Limoges	Limoges	France	42
Chu Lyon	Lyon	France	22
CHU Nancy	Nancy	France	24
CHU Nantes	Nantes	France	86
CHU Nîmes - Carémeau	Nîmes	France	1
CHU Pitié-Salpêtrière	Paris	France	1
CHU Poitiers	Poitiers	France	70
CHU Rennes	Rennes	France	21
CHU Strasbourg-Hôpital Hautepierre	Strasbourg	France	1
CHU Tours	Tours	France	36
Hôpital Cochin	Paris	France	1

Clinical trials